CSPC Pharmaceutical Group (HKG:1093) plans to further buy back shares on the market for up to HK$5 billion including the buyback plan of HK$1 billion approved earlier.
The company has already utilized HK$773 million of the HK$1 billion buyback plan to repurchase 163,860,000 shares as of Thursday, a same-day filing with the Hong Kong Exchange said.
The bought-back shares will be cancelled, the disclosure said.
CSPC Pharmaceutical Group had already repurchased shares for HK$387 million in the first half of this year.
Shares of the company rose 1% at close of Thursday trade.
Price (HKD): $4.69, Change: $+0.040, Percent Change: +0.86%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。